Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;41(4):1125-1131.
doi: 10.1007/s00345-023-04317-y. Epub 2023 Feb 16.

Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia

Manolis Pratsinis  1   2 , Gautier Müllhaupt  3 , Sabine Güsewell  4 , Patrick Betschart  3 , Valentin Zumstein  3 , Daniel Engeler  3 , Hans-Peter Schmid  3 , Alastair D Lamb  5   6 , Dominik Abt  7
Affiliations

Comparison of traditional outcome measures and self-assessed goal achievement in patients treated surgically for benign prostatic hyperplasia

Manolis Pratsinis et al. World J Urol. 2023 Apr.

Abstract

Purpose: To determine self-assessed goal achievement (SAGA) outcomes in men treated surgically for lower urinary tract symptoms (LUTS) due to benign prostatic obstruction (BPO) and compare them to the traditional outcome measures.

Methods: Single-center analysis of prospective database of men undergoing surgical treatment of LUTS/BPO at a single institution between July 2019 and March 2021. We assessed individual goals, traditional questionnaires, and functional outcomes prior to treatment, and at first follow-up after 6-12 weeks. We compared SAGA outcomes 'overall goal achievement' and 'satisfaction with treatment' to subjective and objective outcomes using Spearman's rank correlations (rho).

Results: A total of sixty-eight patients completed the individual goal formulation prior to surgery. Preoperative goals varied between different treatments and individuals. IPSS correlated with 'overall goal achievement' (rho = - 0.78, p < 0.001) and 'satisfaction with treatment' (rho = - 0.59, p < 0.001). Similarly, the IPSS-QoL was correlated with overall goal achievement (rho = - 0.79, p < 0.001) and satisfaction with treatment (rho = - 0.65, p < 0.001). No correlation was seen between SAGA outcomes and functional outcomes Qmax and PVR.

Conclusions: SAGA represents a uniquely patient-specific outcome measure. Our study is, to our knowledge, the first to assess patient-specific goals prior to surgery and examine SAGA outcomes following treatment in men suffering from LUTS/BPO. The correlation of SAGA outcomes with IPSS and IPSS-QoL highlight the importance of this well-established questionnaire. Functional outcomes do not necessarily reflect patient's goals and may rather be considered physician-directed outcomes.

Keywords: Benign prostatic hyperplasia; Bladder outlet obstruction; Decision-making; Lower urinary tract symptoms; Patient satisfaction; Patient-reported outcome measures; Self-assessed goal achievement.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Nair SM, Pimentel MA, Gilling PJ (2015) Evolving and investigational therapies for benign prostatic hyperplasia. Can J Urol 22(Suppl 1):82–87 - PubMed
    1. Malde S, Umbach R, Wheeler JR, Lytvyn L, Cornu JN, Gacci M et al (2021) A systematic review of patients’ values, preferences, and expectations for the diagnosis and treatment of male lower urinary tract symptoms. Eur Urol 79:796–809 - DOI - PubMed
    1. Yao MW, Green JSA (2022) How international is the International Prostate Symptom Score? A literature review of validated translations of the IPSS, the most widely used self-administered patient questionnaire for male lower urinary tract symptoms. Low Urin Tract Symptoms 14:92–101 - DOI - PubMed
    1. Eckhardt MD, van Venrooij GE, van Melick HH, Boon TA (2001) Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being. J Urol 166:563–568 - DOI - PubMed
    1. Ashford S, Turner-Stokes L (2006) Goal attainment for spasticity management using botulinum toxin. Physiother Res Int 11:24–34 - DOI - PubMed

LinkOut - more resources